Literature DB >> 4361298

Antibody against Clostridium perfringens type A enterotoxin in human sera.

T Uemura, C Genigeorgis, H P Riemann, C E Franti.   

Abstract

Antibody against Clostridium perfringens type A enterotoxin was found in 82% of Brazilian and 65% of American serum samples.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4361298      PMCID: PMC414826          DOI: 10.1128/iai.9.2.470-471.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  8 in total

1.  HEMAGGLUTINATION STUDIES WITH FORMALINIZED ERYTHROCYTES. EFFECT OF BIS-DIAZO-BENZIDINE AND TANNIC ACID TREATMENT ON SENSITIZATION BY SOLUBLE ANTIGEN.

Authors:  W T BUTLER
Journal:  J Immunol       Date:  1963-05       Impact factor: 5.422

2.  Purification and biochemical properties of Clostridium perfringens type A enterotoxin.

Authors:  R L Stark; C L Duncan
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

3.  Purification and characteristics of the enterotoxin of Clostridium perfringens type A.

Authors:  A H Hauschild; R Hilsheimer
Journal:  Can J Microbiol       Date:  1971-11       Impact factor: 2.419

4.  The micro-slide gel double diffusion test for the detection and assay of staphylococcal enterotoxins.

Authors:  E P Casman; R W Bennett; A E Dorsey; J E Stone
Journal:  Health Lab Sci       Date:  1969-10

5.  Biological characteristics of Clostridium perfringens type A enterotoxin.

Authors:  R L Stark; C L Duncan
Journal:  Infect Immun       Date:  1971-08       Impact factor: 3.441

6.  Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes.

Authors:  H D Hochstein; J C Feeley; W E DeWitt
Journal:  Appl Microbiol       Date:  1970-05

7.  In vitro detection of antibody to cholera enterotoxin in cholera patients and laboratory animals.

Authors:  R A Finkelstein; J W Peterson
Journal:  Infect Immun       Date:  1970-01       Impact factor: 3.441

8.  Improved medium for sporulation of Clostridium perfringens.

Authors:  C L Duncan; D H Strong
Journal:  Appl Microbiol       Date:  1968-01
  8 in total
  5 in total

1.  Detection of Clostridium perfringens enterotoxin in human fecal samples and anti-enterotoxin in sera.

Authors:  H S Naik; C L Duncan
Journal:  J Clin Microbiol       Date:  1978-04       Impact factor: 5.948

2.  Fluid accumulation in mouse ligated intestine inoculated with Clostridium perfringens enterotoxin.

Authors:  K Yamamoto; I Ohishi; G Sakaguchi
Journal:  Appl Environ Microbiol       Date:  1979-02       Impact factor: 4.792

3.  Age related variations of serum concentrations of normally occurring IgG antibodies to Clostridium perfringens.

Authors:  E Zarén; A Schwan; B Frenckner
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

4.  Effects of pH shifts, bile salts, and glucose on sporulation of Clostridium perfringens NCTC 8798.

Authors:  C S Hickey; M G Johnson
Journal:  Appl Environ Microbiol       Date:  1981-01       Impact factor: 4.792

5.  Clinical and antibody responses to Clostridium perfringens type A enterotoxin in experimental sheep and calves.

Authors:  L Niilo; H J Cho
Journal:  Can J Comp Med       Date:  1985-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.